Neuroendocrine Differentiation Is a Prognostic Factor for Stage II Poorly Differentiated Colorectal Cancer

<table>IHC of CgA ((a), (b), and (c)) and Syn ((d), (e), and (f)) (400x). Subgroup 1, (a) and (d), scattered stained, 1–10 NED(+) tumor cells/HPF; subgroup 2, (b) and (e), focally stained, 11–20 NED(+) tumor cells/HPF; subgroup 3, (c) and (f), clustered or pathy stained, &gt;20 NED(+) tumor cells/HPF.</table>

BioMed Research International

fig1

Figure 1

Figure 1: Neuroendocrine Differentiation Is a Prognostic Factor for Stage II Poorly Differentiated Colorectal Cancer 